Symphony Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-15,193
Closed -$961K 196
2018
Q2
$961K Sell
15,193
-1,540
-9% -$83.2K 0.19% 116
2018
Q1
$1.06M Sell
16,733
-12,601
-43% -$811K 0.14% 162
2017
Q4
$1.8M Sell
29,334
-10,074
-26% -$630K 0.18% 129
2017
Q3
$2.51M Buy
39,408
+26,865
+214% +$1.57M 0.28% 85
2017
Q2
$699K Sell
12,543
-611
-5% -$33.2K 0.08% 224
2017
Q1
$715K Sell
13,154
-8,922
-40% -$489K 0.07% 243
2016
Q4
$1.29M Sell
22,076
-762
-3% -$41.7K 0.13% 163
2016
Q3
$1.23M Sell
22,838
-1,220
-5% -$78.4K 0.13% 170
2016
Q2
$1.77M Sell
24,058
-1,237
-5% -$87.4K 0.19% 139
2016
Q1
$1.62M Sell
25,295
-674
-3% -$42.5K 0.17% 136
2015
Q4
$1.79M Sell
25,969
-580
-2% -$38.3K 0.2% 121
2015
Q3
$1.57M Sell
26,549
-785
-3% -$49.8K 0.19% 130
2015
Q2
$1.82M Buy
27,334
+15,180
+125% +$1M 0.23% 119
2015
Q1
$784K Sell
12,154
-4,883
-29% -$306K 0.09% 214
2014
Q4
$1.01M Sell
17,037
-3,987
-19% -$225K 0.13% 169
2014
Q3
$1.08M Sell
21,024
-19,916
-49% -$995K 0.11% 173
2014
Q2
$1.99M Buy
40,940
+1,658
+4% +$81.7K 0.21% 128
2014
Q1
$2.04M Buy
39,282
+3,528
+10% +$188K 0.19% 140
2013
Q4
$1.9M Buy
35,754
+11,950
+50% +$609K 0.14% 144
2013
Q3
$1.1M Sell
23,804
-7,824
-25% -$343K 0.11% 171
2013
Q2
$1.41M Buy
+31,628
New +$1.37M 0.14% 145

Other funds holding BMY

Symphony Asset Management's BMY Position: Q3 2018 in Review

Symphony Asset Management sold out of Bristol-Myers Squibb (BMY) in Q3 2018, closing a stake of 15,193 shares — an estimated $961K sold.

Symphony Asset Management first reported a position in BMY in Q2 2013 and held it in 21 quarters. The position peaked at $2.51M in Q3 2017. 1,729 funds tracked by Wall St. Rank hold BMY as of Q3 2018.

  • Symphony Asset Management reported no remaining Bristol-Myers Squibb position as of Q3 2018 after selling out during the quarter.
  • Symphony Asset Management sold 15,193 Bristol-Myers Squibb shares in Q3 2018, an estimated $961K.
  • Symphony Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 21 quarters.
  • Symphony Asset Management's Bristol-Myers Squibb position peaked at $2.51M in Q3 2017.
  • 1,729 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2018.

Based on Symphony Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.